Maze Cord Blood

What Maze Cord Blood does

Maze Cord Blood Laboratories is a privately held, US-based cord blood and cord tissue banking service operating as part of the Maze Health group and headquartered in Westchester, New York. The company collects, processes, and cryogenically stores hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue on behalf of expectant-parent families for potential future medical use in treating blood disorders, cancers, immune deficiencies, and regenerative medicine applications.

The company's core technical differentiator is the proprietary TissueQES processing method, which provides quantitative post-thaw evaluation of stem cell survival — a verification step most competitors do not perform. Operations are conducted under multiple industry accreditations (AABB, CAP, FACT, CLIA). The business runs on a subscription model: customers pay upfront processing fees at enrollment plus recurring annual storage fees for the duration of custody, typically aligned to a 20-year horizon from the child's birth date. Distribution is direct-to-consumer via phone-based enrollment and the company website.

As of 2024, Maze Cord Blood has ceased accepting new enrollments and redirects prospective customers to its partner MiracleCord, while continuing to store and service all previously collected units. The company is founder-owned and led, with no disclosed institutional capital, and operates with a small staff (11–50 employees). The commercial implication is that the asset is operating in a managed run-off posture, with revenue bounded to the existing installed base.

Name

Maze Cord Blood

Legal name

Maze Cord Blood Laboratories

Website

https://mazecordblood.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Maze Cord Blood is a private US cord blood and tissue banking service that stores newborn stem cells for expectant-parent families. A subsidiary of Maze Health, it is no longer accepting new enrollments and now operates as a managed run-off, servicing its existing storage book.

Ownership category

akta.pro rank

Product category

Cord Blood Banking

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industry

Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics (HLAGAMAE)

Keywords

• Cord blood banking
• Cord tissue banking
• Stem cell storage
• Cryogenic preservation
• Stem cell banking

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Cord Blood Banking Storage: Annual subscription-based storage fees for cord blood and cord tissue units. Customers pay processing fees upfront and annual storage fees for continued preservation of their biological samples.
2. Cord Tissue Banking Storage: Annual subscription-based storage fees for umbilical cord tissue containing mesenchymal stem cells (MSCs). Stored separately from cord blood for potential future regenerative medicine applications.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Maze Cord Blood collects, processes, and cryogenically stores umbilical cord blood and umbilical cord tissue from newborns for private family use. Customers pay an upfront processing fee and recurring annual storage fees to preserve hematopoietic stem cells from cord blood and mesenchymal stem cells (MSCs) from cord tissue for potential future treatment of blood disorders, cancers, immune deficiencies, metabolic disorders, and regenerative medicine applications. The company is no longer accepting new enrollments and refers prospective customers to partner MiracleCord, while continuing to store all previously collected units.

Product overview

Maze Cord Blood operates as a private cord blood and tissue banking service. The company offers two core storage services: Cord Blood Banking (storage of hematopoietic stem cells from umbilical cord blood) and Cord Tissue Banking (storage of mesenchymal stem cells from umbilical cord tissue). A key proprietary feature is the TissueQES processing method, which provides quantitative evaluation of stem cell survival via post-thaw growth verification. The company is no longer accepting new enrollments but continues to store previously collected units.

Differentiator

Problem solved

Functional benefit

Products and services

• Cord Blood Banking Private cord blood banking service that collects, processes, and cryogenically stores umbilical cord blood rich in hematopoietic stem cells for a family's potential future medical use, including treatment of over 80 blood and immune disorders and cancers.
• Cord Tissue Banking Private cord tissue banking service that collects and stores umbilical cord tissue rich in mesenchymal stem cells (MSCs) for potential future regenerative therapies, including orthopedic and cardiac applications, stored separately from cord blood.

Named customers7 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• MiracleCordcoreChannel Partner/ Reseller/ DistributorReferral partnership where Maze Cord Blood directs new enrollment inquiries to MiracleCord. The companies have an established relationship for cord blood banking services. Maze continues to store all previously collected cord blood units while MiracleCord handles new customer enrollments. Customers can call MiracleCord at 888-435-5550 or visit MiracleCord.com.

Recent moves4 records

Expansion highlights3 records

Direct peers

• StemCyte: Hybrid private and public cord blood bank operating cord blood banking, processing, and therapeutic applications. Comparable in laboratory accreditation profile and core service offering, though with a stronger hybrid public-bank component.
• Cryo-Cell International: Public company (CYCC) operating one of the longest-standing private cord blood and tissue banking services. Directly comparable service offering, customer base, and subscription revenue model, but with greater scale and public-market capital access.
• Americord Registry: Private cord blood and tissue bank offering family banking services including cord blood, cord tissue, and placenta-derived stem cells. Competes with Maze on affordability and product breadth for expectant-parent customers.
• FamilyCord: Private family cord blood bank offering cord blood and cord tissue banking with comparable accreditation (AABB, CLIA). Targets the same expectant-parent buyer with a similar value proposition around affordability and quality.
• MiracleCord: Direct-to-consumer cord blood and tissue bank explicitly named as Maze's referral partner for new enrollments. Operates the same business model (private family banking, AABB-accredited processing) and serves the same expectant-parent segment in the US market.
• LifebankUSA: Private cord blood and tissue bank (a Celularity company) offering family banking services. Comparable product set (cord blood, cord tissue, placental stem cells) and US customer segment to Maze.
• CorCell: Private cord blood and tissue banking service focused on family banking with a comparable product set (cord blood, cord tissue) and similar subscription storage model. Competes for the same expectant-parent customers.

Regional players

• New York Blood Center: Large nonprofit blood banking organization headquartered in New York with public cord blood banking operations through the National Cord Blood Program. Operates a related but public-banked model in Maze's home geography, offering an alternative to family banking.

Broad incumbents

• ViaCord: Established private cord blood bank owned by Revvity (formerly PerkinElmer). Offers cord blood and cord tissue banking with similar accreditation profile to Maze and competes for the same affluent, health-conscious expectant-parent segment.
• CBR (Cord Blood Registry): One of the largest US private cord blood banks, historically part of CBR Systems and now part of CooperCompanies. Competes head-to-head with Maze for expectant-parent customers and has substantially greater scale, marketing budget, and brand recognition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Maze_CordBlood
• YouTubeyoutube.com/user/MazeCordBlood
• Facebookfacebook.com/mazecordblood
• Instagraminstagram.com/maze_cordblood
• Pinterestpinterest.com/mazecordblood/pins

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maze Cord Blood